News • Rhinovirus
Common cold combats influenza
Rhinovirus, the most frequent cause of common colds, can prevent the flu virus from infecting airways by jumpstarting the body's antiviral defenses.
Virus
News • Coronavirus
“Hotspots” of a corona infection in the human body
An infection with the coronavirus SARS-CoV-2 can affect multiple organs. With this in mind, researchers of the German Center for Neurodegenerative Diseases (DZNE) and Cornell University in the US have investigated cellular factors that could be significant for an infection. To this end, they analysed the activity of 28 specific genes in a wide range of human tissues.
News • Electrostatic interactions
New research exposes weak spot in SARS-CoV-2
Northwestern University researchers have uncovered a new vulnerability in the novel coronavirus’ infamous spike protein — illuminating a relatively simple, potential treatment pathway. The spike protein contains the virus’ binding site, which adheres to host cells and enables the virus to enter and infect the body. Using nanometer-level simulations, the researchers discovered a positively…
News • Researchers use supercomputer
New insights into hepatitis B
Researchers at the University of Delaware, using supercomputing resources and collaborating with scientists at Indiana University, have gained new understanding of the virus that causes hepatitis B and the "spiky ball" that encloses the virus's genetic blueprint.
News • Droplet spread simulation
Mathematical model to predict the spread of airborne diseases
A new mathematical model is helping develop the current understanding of how airborne diseases such as COVID-19 can spread during breathing and aerosol generating procedures. Researchers from Heriot-Watt University and the University of Edinburgh have developed a mathematical model of droplet migration. Dr Cathal Cummins of Heriot-Watt’s School of Mathematical and Computer Sciences and…
Article • Re-evaluation of the coronavirus disease
COVID-19: A tale of two conditions
The SARS CoV-2 virus which causes COVID-19 may have been named prematurely. As more has become known about the infection, the severe disease does not appear to be a respiratory syndrome at all. Patients who only have a respiratory illness tend not to have a severe condition, while patients who develop a severe condition tend to have non-respiratory conditions, primarily thrombotic or hyper-immune…
News • Coronavirus
Lab-made virus mimics COVID-19 virus
Airborne and potentially deadly, the virus that causes COVID-19 can only be studied safely under high-level biosafety conditions. Scientists handling the infectious virus must wear full-body biohazard suits with pressurized respirators, and work inside laboratories with multiple containment levels and specialized ventilation systems. While necessary to protect laboratory workers, these safety…
News • Soaking up SARS-CoV-2
Nanosponges could intercept coronavirus infection
Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce.
Article • Disinfection
Robots help fight hospital infections
In the hustle and bustle of a hospital, properly disinfecting all surfaces in a patient room can be a challenging and time-consuming task. Now, in times of the coronavirus pandemic, it can also be life-threatening. To minimize the risk for their staff, hospitals are utilizing disinfection robots to sanitize surfaces and rooms.
News • Viral oncology
Kaposi Sarcoma: Answers to a longstanding enigma
The oncogenic herpesvirus (HHV8 or KSHV) causes a cancer known as Kaposi’s Sarcoma. An international team of scientists led by the University of Helsinki has discovered key factors that control the genome maintenance and replication of a virus responsible for lymphatic vascular cancer. Kaposi Sarcoma (KS) is the most common cancer among Aids patients and it is often seen in sub Saharan and…
News • COVID-19 detection
New analyzer detects virus antibodies in 20 minutes
Researchers at Hokkaido University have succeeded in detecting anti-avian influenza virus antibody in blood serum within 20 minutes, using a portable analyzer they have developed to conduct rapid on-site bio tests. If a suitable reagent is developed, this technology could be used to detect antibodies against SARS-CoV-2, the causative virus of COVID-19.
Article • Infection control in hospitals
Nosocomial influenza: The enormous effect of mask wearing
The Coronavirus dominates everyday conversation as well as medical and scientific discussions, but in a Leipzig hygiene congress, other topics – such as nosocomial influenza – took a strong position. Dr Andreas Ambrosch, head of the Institute of Laboratory Medicine, Microbiology and Hospital Hygiene at the Brothers of Mercy Hospital in Regensburg, Germany, presented a new study on the spread…
News • COVID-19 infections
Genetic network analysis provides 'snapshot' of pandemic origins
Researchers from Cambridge, UK, and Germany have reconstructed the early “evolutionary paths” of COVID-19 in humans – as infection spread from Wuhan out to Europe and North America – using genetic network techniques.
News • COVID-19 research
Clues to coronavirus’s vulnerability emerge from SARS antibody
An antibody recovered from a survivor of the SARS epidemic in the early 2000s has revealed a potential vulnerability of the new coronavirus at the root of COVID-19, according to a study from scientists at Scripps Research. The study, published in Science, is the first to map a human antibody’s interaction with the new coronavirus at near-atomic-scale resolution. Although the antibody was…
News • Flu forecast
Portable AI device predicts outbreaks based on coughing
University of Massachusetts Amherst researchers have invented a portable surveillance device powered by machine learning – called FluSense – which can detect coughing and crowd size in real time, then analyze the data to directly monitor flu-like illnesses and influenza trends. The FluSense creators say the new edge-computing platform, envisioned for use in hospitals, healthcare waiting rooms…
News • COVID-19 longevity
How long can the coronavirus persist on surfaces?
How long can coronavirus persist on surfaces such as door handles or hospital nightstands? How can the virus be destroyed effectively? A research team from Greifswald and Bochum, Germany, collected the answers scientists can currently offer to these and other pertinent questions and published them in the Journal of Hospital Infection.
News • COVID-19 medication safety
New traffic light system to prevent coronavirus drug interaction
The University of Liverpool launched a new website featuring a traffic light system to aid the safe prescribing of experimental drugs being trialled against coronavirus (COVID-19). The site, created by the University’s Liverpool Drug Interactions Group, provides vital information on whether or not combinations of an experimental drug and co-medications are safe to prescribe. This is of…
News • COVID-19 update
WHO labels coronavirus disease as a pandemic
The World Health Organization (WHO) has officially categorized the current outbreak of the novel coronavirus disease (COVID-19) as a pandemic. Speaking at the COVID-19 media briefing, the WHO Director-General Dr Tedros Adhanom said: "WHO has been assessing this outbreak around the clock and we are deeply concerned both by the alarming levels of spread and severity, and by the alarming levels…
News • Computer-aided search for substances
Virtual screening for anti-coronavirus drugs
The University of Basel is part of the global search for a drug to fight the rampant coronavirus SARS-CoV-2. Researchers in the Computational Pharmacy group have so far virtually tested almost 700 million substances, targeting a specific site on the virus – with the aim of inhibiting its multiplication.
News • At-home testing for COVID-19
Coronavirus testing? There's an app for that
A coronavirus app coupled with machine intelligence will soon enable an individual to get an at-home risk assessment based on how they feel and where they’ve been in about a minute, and direct those deemed at risk to the nearest definitive testing facility, investigators say. It will also help provide local and public health officials with real time information on emerging demographics of those…
News • Pandemic prevention
German lab developed coronavirus detection method
Investigators at Hannover Medical School (MHH) in Germany have developed a molecular assay for detecting the novel coronavirus SARS-CoV-2 (previously 2019-nCoV) on the automated Panther Fusion system by Hologic. The preclinical assay is described online in the Journal of Clinical Virology. “Rapid diagnosis is critical to combatting the spread of pandemics, and the Panther Fusion system is well…
News • Radiology congress (update)
ECR 2020 will be online-only due to coronavirus
The 2020 edition of the European Congress of Radiology (ECR) in Vienna, which had been postponed due to safety concerns regarding COVID-19, will not take place on site this year. Instead, the congress organisers at the European Society of Radiology (ESR) opt for an online-only event: "It is with a heavy heart and much regret that the Board of Directors of the European Society of Radiology…
News • EUA for respirators issued
Coronavirus: U.S. permits more protective masks for healthcare setting
In a joint effort, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) take action to make more respirators, including certain N95s, available to health care personnel. Currently, the majority of respirators on the market are indicated for use in industrial settings. This action allows certain National Institute for Occupational Safety and Health…
News • COVID-19 in radiology
CT outperforms lab diagnosis for coronavirus infection
In a study of more than 1,000 patients published in Radiology, chest CT outperformed lab testing in the diagnosis of 2019 novel coronavirus disease (COVID-19). Researchers at Tongji Hospital in Wuhan, China, concluded that CT should be used as the primary screening tool for COVID-19. In the absence of specific therapeutic drugs or vaccines for COVID-19, it is essential to detect the disease at an…
News • Pilot clinical trial
China to test targeted therapy for COVID-19
A University of British Columbia (UBC) researcher is part of an international team working with a biotechnology company on a pilot clinical trial of a potential new treatment for patients with severe coronavirus infections in China. Dr. Josef Penninger, director of UBC’s Life Sciences Institute and Canada 150 Chair in Functional Genetics, is working closely with Vienna-based Apeiron Biologics…